Physician profile
Obie Ramsay
NPI 1952504789
$1,204.93
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $262 · 2023: $22.53 · 2024: $33.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $427.18 | 2019-2020 | |
| Lilly USA, LLC | $128.37 | 2019 | |
| Genentech USA, INC. | $112.76 | 2019 | |
| Novo Nordisk INC | $99.95 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $93.54 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $92.63 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $51.35 | 2019 | |
| Janssen Biotech, INC. | $37.21 | 2019 | |
| Ucb, INC. | $30.62 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $29.50 | 2019 | |
| Celgene Corporation | $17.59 | 2019 | |
| Medtronic Vascular, INC. | $14.16 | 2019 | |
| Abbvie INC. | $14.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.87 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obie Ramsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.